hesperetin and Cardiotoxicity

hesperetin has been researched along with Cardiotoxicity in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Eltelbany, RFA; Khalil, HMA; Rasheed, RA; Zaafar, D; Zaitone, SA1
Chang, J; Li, F; Li, X; Yan, A; Zhu, J1

Other Studies

2 other study(ies) available for hesperetin and Cardiotoxicity

ArticleYear
Hesperetin mitigates sorafenib-induced cardiotoxicity in mice through inhibition of the TLR4/NLRP3 signaling pathway.
    PloS one, 2022, Volume: 17, Issue:8

    Topics: Animals; Cardiotoxicity; Hesperidin; Interleukin-6; Male; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; Signal Transduction; Sorafenib; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha

2022
[Hesperetin Alleviates Doxorubicin-Induced Cytotoxicity in H9c2 Cells by Activating SIRT1/NRF2 Signaling].
    Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2023, Volume: 54, Issue:5

    Topics: Apoptosis; Cardiotoxicity; Caspase 3; Cytochromes c; Doxorubicin; Humans; Myocytes, Cardiac; NF-E2-Related Factor 2; Oxidative Stress; Reactive Oxygen Species; Sirtuin 1; Superoxide Dismutase

2023